Gene · 51441
Papers3,768
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,768
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Altered Expression of m6A-Associated Genes Is Linked with Poor Prognosis in Pediatric Acute Myeloid Leukemia Patients. | Biomolecules | 2025 | 41008545 | PubTator, text mining | PubMed |
| Lumpy Skin Disease Virus ORF137 Protein Inhibits Type I Interferon Production by Interacting with and Decreasing the Phosphorylation of IRF3. | Cells | 2025 | 41002440 | PubTator, text mining | PubMed |
| PDGFC facilitates enzalutamide resistance in prostate cancer through activation of the Rap1-MAPK pathway. | J Cancer Res Clin Oncol | 2025 | 40993441 | PubTator, text mining | PubMed |
| The m6A modification in cancer: roles, implications, and its potential in therapy. | Mol Biomed | 2025 | 40986143 | PubTator, text mining | PubMed |
| m6A RNA Methylation in Psychiatric Disorders: An Emerging Epitranscriptomic Axis. | Epigenomes | 2025 | 40981072 | PubTator, text mining | PubMed |
| YTHDF2 drives oral squamous cell carcinoma progression via m6A-dependent degradation of MTUS1/ATIP1 mRNA and mitochondrial dysregulation. | Cell Signal | 2025 | 40975502 | PubTator, text mining | PubMed |
| Maintenance of neuronal TDP-43 expression requires axonal lysosome transport. | Elife | 2025 | 40970386 | PubTator, text mining | PubMed |
| FTO-m6A demethylation in cerebral I/R injury: Dual regulation of cell death and neuroinflammation towards therapeutic translation: A review. | Int J Biol Macromol | 2025 | 40967548 | PubTator, text mining | PubMed |
| YAP regulates the hypertrophy and apoptosis of antler chondrocytes through maintaining calcium homeostasis and mitochondrial function. | Cell Signal | 2025 | 40957486 | PubTator, text mining | PubMed |
| METTL3 promotes ovarian cancer progression through YTHDF2-dependent degradation of GATA4. | Pathol Res Pract | 2025 | 40945198 | PubTator, text mining | PubMed |
| O-GlcNAcylated YTHDF2 promotes bladder cancer progression by regulating the tumor suppressor gene PER1 via m6A modification. | Zhong Nan Da Xue Xue Bao Yi Xue Ban | 2025 | 40916820 | PubTator, text mining | PubMed |
| Cancer Cell-Secreted miR-33a Reduces Stress Granule Formation by Targeting Polyamine Metabolism in Stroma to Promote Tumourigenesis. | J Extracell Vesicles | 2025 | 40903826 | PubTator, text mining | PubMed |
| m1A methylase TRMT6 promotes neuroblastoma development by demethylating SST mRNA in an m1A/YTHDF2-dependent manner. | Br J Cancer | 2025 | 40897821 | PubTator, text mining | PubMed |
| IDH1-dependent m6A methylation defines transcriptomic heterogeneity in glioma. | medRxiv | 2025 | 40894120 | PubTator, text mining | PubMed |
| Identification and experimental validation of biomarkers related to mitochondrial and programmed cell death in obsessive-compulsive disorder. | Sci Rep | 2025 | 40885831 | PubTator, text mining | PubMed |
| YTHDF3-associated m6A regulation and cuproptosis-related gene expression in steroid-induced osteonecrosis of the femoral head. | J Mol Histol | 2025 | 40879675 | PubTator, text mining | PubMed |
| Integrated analysis of m6A regulator mediated RNA methylation and key immune related genes in ischemic stroke. | Sci Rep | 2025 | 40877397 | PubTator, text mining | PubMed |
| Harnessing the Loop: The Perspective of Circular RNA in Modern Therapeutics. | Vaccines (Basel) | 2025 | 40872908 | PubTator, text mining | PubMed |
| Roles and Prospective Applications of Ferroptosis Suppressor Protein 1 (FSP1) in Malignant Tumor Treatment. | Curr Oncol | 2025 | 40862825 | PubTator, text mining | PubMed |
| Post-Translational Modifications in Mammalian Folliculogenesis and Ovarian Pathologies. | Cells | 2025 | 40862771 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51441/papers?page=11